[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636817":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":10,"responsibleParty":25,"collaborators":10,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":10,"eligibilityCriteria":33,"healthyVolunteers":29,"sex":34,"minAge":35,"maxAge":10,"enrollmentInfo":36,"targetDuration":10,"studyType":39,"phases":10,"briefSummary":40,"conditions":41,"keywords":10,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":51,"leadSponsor":53,"locationsCount":10},{"fullName":5,"class":6},"Chinese Pulmonary Vascular Disease Research Group","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"PAH Patients",null,"Patients diagnosed with pulmonary arterial hypertension participating in a prospective observational study and completing quality of life questionnaires.",[13],"Other: Questionnaire Assessment",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Questionnaire Assessment","Participants complete quality of life questionnaires and clinical data are collected. No therapeutic intervention is applied.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Qin Luo","CONTACT","13581777615","luoqin2009@163.com",{"type":26,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100636817","development-and-validation-of-a-chinese-quality-of-life-scale-for-pulmonary-arterial-hypertension-100636817",false,"NCT07570615","Development and Validation of a Chinese Quality of Life Scale for Pulmonary Arterial Hypertension","Development and Validation of a Chinese Patient-Reported Outcome Measure for Quality of Life in Pulmonary Arterial Hypertension Patients","Inclusion Criteria:\n\n* Age ≥18 years\n* Diagnosed with pulmonary arterial hypertension\n* Able to read and complete questionnaires\n* Provided informed consent\n\nExclusion Criteria:\n\n* Severe physical condition preventing participation\n* History of psychiatric disorders or current use of psychiatric medication\n* Pregnancy or lactation\n* Any condition preventing completion of questionnaires","ALL","18 Years",{"count":37,"type":38},300,"ESTIMATED","OBSERVATIONAL","This study aims to develop and validate a culturally appropriate, reliable, and clinically applicable patient-reported outcome (PRO) instrument to assess quality of life in patients with pulmonary arterial hypertension (PAH) in China.\n\nThe study includes two phases: (1) scale development using literature review, Delphi expert consultation, and patient interviews; and (2) multicenter prospective observational validation to evaluate reliability, validity, and responsiveness.\n\nThe final scale is expected to support clinical assessment, treatment monitoring, and health policy decision-making.",[42,43,44],"Pulmonary Arterial Hypertension (PAH)","Quality of Life","Patients Reported Outcomes","NOT_YET_RECRUITING","2026-04-30",{"date":48,"type":49},"2026-05-06","ACTUAL",{"date":46,"type":38},{"date":52,"type":38},"2029-04-30",{"name":5,"class":6}]